Taken together, these findings suggest that cDC1 play an important role across a range of kidney diseases including ATN, interstitial fibrosis in immune-mediated disease and crescent formation, and that they may potentially act through activation of CD8+ T cells. This evidence concerns the gene CD8A and kidney disorder.